Next big COVID-19 treatment may be manufactured antibodies

Published on August 4, 2020

Development of monoclonal antibodies to target the virus has been endorsed by leading scientists. Scientists are still working out the exact role of neutralizing antibodies in recovery from COVID-19, but drugmakers are confident that the right antibodies or a combination can alter the course of the disease. Reuters

Other news

EARLY RELEASE: Characteristics and Outcomes of Contacts of COVID-19 Patients Monitored Using an Automated Symptom Monitoring Tool - Maine, May-June 2020

August 3, 2020
This report describes the use of automated symptom monitoring in Maine to promptly identify COVID-19 diagnoses among contacts.

EARLY RELEASE: Vital Signs: Clinical Characteristics of Patients with Confirmed Acute Flaccid Myelitis, United States, 2018

August 4, 2020
This report describes symptoms, physical findings, test and imaging results, and hospitalization data of patients with confirmed acute flaccid myelitis during 2018.